Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
3.87 USD | 0.00% | -7.42% | -9.37% |
Kurzporträt
Mitarbeiterzahl: 128
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Krishna Vaddi
FOU | Founder | 58 | 01.02.16 |
Bryant Lim
DFI | Director of Finance/CFO | 53 | 01.02.23 |
Jane Huang
PSD | President | 51 | 04.04.22 |
Wan-Jen Hong
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
Madhu Pudipeddi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Aimee Crombie
COO | Chief Operating Officer | - | 01.01.18 |
Peggy Scherle
CTO | Chief Tech/Sci/R&D Officer | 62 | 01.04.18 |
Lindsey Trickett
IRC | Investor Relations Contact | - | - |
Michele Porreca
HRO | Human Resources Officer | - | 01.06.21 |
Andrew Combs
PRN | Corporate Officer/Principal | 58 | 01.04.19 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Julian Baker
BRD | Director/Board Member | 57 | 25.01.21 |
Paul Friedman
CHM | Chairman | 81 | 01.07.16 |
David Bonita
BRD | Director/Board Member | 48 | 01.07.16 |
Mardi Dier
BRD | Director/Board Member | 60 | 01.08.20 |
Martin Babler
BRD | Director/Board Member | 59 | 19.07.21 |
Victor Sandor
BRD | Director/Board Member | 57 | 01.05.20 |
Krishna Vaddi
FOU | Founder | 58 | 01.02.16 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 54 920 594 | 51 116 607 ( 93,07 %) | 0 | 93,07 % |
Unternehmenskontakt
Sektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-9.37% | 212 Mio. | |
+4.09% | 43.43 Mrd. | |
+47.81% | 41.69 Mrd. | |
+9.45% | 41.31 Mrd. | |
-10.92% | 27.14 Mrd. | |
+9.32% | 25.28 Mrd. | |
-24.87% | 18.47 Mrd. | |
+29.70% | 12.59 Mrd. | |
+1.28% | 12.33 Mrd. | |
+7.78% | 11.03 Mrd. |
- Börse
- Aktien
- A2QDGN Aktie
- Unternehmen Prelude Therapeutics Incorporated